Life expectancy with HIV nears normal with treatment
(HealthDay)—Young adults with HIV who get treatment are living longer in North America and Europe, a new study finds.
May 11, 2017
0
0
(HealthDay)—Young adults with HIV who get treatment are living longer in North America and Europe, a new study finds.
May 11, 2017
0
0
Mothers in the early phases of HIV infection who continued antiretroviral therapy (ART) postpartum experienced a significantly slower rate of disease progression than those who stopped using ART after delivery, according ...
May 10, 2017
0
1
(HealthDay)—A small proportion of HIV-infected women continue to transmit the virus to their neonates despite access to high-quality care, according to research published in the April issue of Obstetrics & Gynecology.
Mar 13, 2017
0
2
An inexpensive and readily accessible anti-inflammatory drug reduces the risk of a potentially dangerous complication in patients starting treatment for both TB and HIV.
Feb 27, 2017
0
1
A comprehensive collection of articles describing the broad scope and current status of this global effort is published in a special issue of AIDS Research and Human Retroviruses.
Feb 10, 2017
0
12
A drug developed at the University of Rochester Medical Center extends the effectiveness of multiple HIV therapies by unleashing a cell's own protective machinery on the virus. The finding, published today in the Journal ...
Jan 30, 2017
0
6
The antiretroviral drugs used to treat HIV infection might inadvertently be boosting gay/bisexual men's susceptibility to the bacteria responsible for syphilis, Treponema pallidum, conclude researchers in the journal Sexually ...
Jan 16, 2017
0
37
In findings they call counterintuitive, a team of UCLA-led researchers suggests that blocking a protein, which is crucial to initiating the immune response against viral infections, may actually help combat HIV.
Dec 23, 2016
0
827
(HealthDay)—A two-way, personalized daily text messaging intervention can improve antiretroviral therapy (ART) adherence among HIV-positive adolescents and young adults, according to a study published in AIDS and Behavior.
Dec 20, 2016
0
0
The administration of VRC01, a potent and broadly neutralizing HIV-specific antibody, is safe, is well-tolerated, generated high plasma concentrations and modestly delayed the return of HIV viral rebound in HIV-1 infected ...
Nov 10, 2016
0
8